Key Events This Week
Mar 2: Stock hits 52-week low at Rs.3.02 amid valuation worries
Mar 4: Price stagnates at Rs.3.10 despite Sensex decline
Mar 5: Further dip to Rs.3.03 on mixed market signals
Mar 6: New 52-week low of Rs.3.01 recorded

Zenith Health Care Ltd Falls to 52-Week Low of Rs.2.5 Amidst Continued Downtrend
2026-03-10 12:40:36Zenith Health Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, has touched a new 52-week low of Rs.2.5 today, marking a significant decline amid ongoing market pressures and company-specific factors. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in its financial and technical performance.
Read full news article
Zenith Health Care Ltd Falls to 52-Week Low of Rs.2.82
2026-03-09 13:20:49Zenith Health Care Ltd, a player in the Pharmaceuticals & Biotechnology sector, touched a new 52-week low of Rs.2.82 today, marking a significant decline in its stock price amid broader market weakness and company-specific financial concerns.
Read full news article
Zenith Health Care Ltd Stock Falls to 52-Week Low of Rs.3.01
2026-03-06 10:27:35Zenith Health Care Ltd’s stock has declined to a fresh 52-week low of Rs.3.01, marking a significant downturn in its market performance amid broader sector and market pressures.
Read full news article
Zenith Health Care Ltd Stock Falls to 52-Week Low of Rs.3.02
2026-03-02 14:20:13Zenith Health Care Ltd’s share price declined sharply to a new 52-week low of Rs.3.02 on 2 Mar 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.
Read full news article
Zenith Health Care Ltd Valuation Shifts Signal Price Attractiveness Concerns
2026-03-02 08:00:40Zenith Health Care Ltd’s valuation metrics have shifted notably, with its price-to-earnings (P/E) and price-to-book value (P/BV) ratios moving the stock into an expensive category relative to its historical averages and peer group. Despite a stagnant share price and underwhelming returns compared to the Sensex, the company’s deteriorating financial performance and valuation upgrade to ‘expensive’ raise questions about its price attractiveness for investors.
Read full news article
Zenith Health Care Ltd Valuation Shifts Signal Changing Market Sentiment
2026-02-24 08:02:18Zenith Health Care Ltd has experienced a notable shift in its valuation parameters, moving from an expensive to a fair valuation territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the pharmaceutical and biotechnology sector’s micro-cap landscape.
Read full news article
Zenith Health Care Ltd Valuation Shifts Signal Elevated Price Risk Amid Weak Returns
2026-02-16 08:04:44Zenith Health Care Ltd has seen a marked shift in its valuation parameters, moving from a risky to an expensive rating, reflecting a significant change in price attractiveness. Despite a modest day gain of 0.60%, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios, when compared to historical averages and peer benchmarks, suggest caution for investors amid deteriorating fundamentals and a challenging sector backdrop.
Read full news article






